Manufacturing and Analytical Services
5 Red Flags That Show Your CRO Isn’t Giving You the Attention You Deserve
Choose a CRO Who Understands Your Worth
Like any good relationship, going steady with a CRO should be about mutual commitment, transparency, and shared goals. But what if your CRO isn’t giving you the time and effort you deserve?
Here are five red flags that show your CRO isn’t making you a priority—and how Altasciences guarantees the support you deserve.
-
You always have to ask for attention.
Are you constantly chasing updates or feeling like an afterthought? It might be time to rethink your partnership. At Altasciences, we believe in the type of commitment where you never have to wonder where you stand or compete with late-phase deliverables. With a dedicated, cross-functional team by your side, you’ll always be a priority. No mixed signals—just clear, proactive updates.
-
They keep changing plans on you.
You’ve agreed on dates, but they’re always running late or delaying your studies. At Altasciences, size and spend don’t matter; whether you place one study or a complete program with us, we stay true to our commitment to you. And if timeline changes are a possibility, we will be able to anticipate them and present solutions before they happen. Our customized roadmaps and centralized scheduling system facilitate active timeline management, real-time responses, and proactive communication; you’ll know what activities are taking place in real time.
-
They’re making you repeat yourself.
If you’re constantly repeating information, they’re not putting in the effort to make your relationship easier. Think of partnering with Altasciences like a honeymoon period that never ends. With our proprietary database, Ask Albert, we capture and share your preferences, study requirements, drug information, and results across all departments and phases. That way, you’ll only have to Tell Us Once™.
-
They’re hard to reach.
If they take eons to respond to your calls or emails, they might be giving you the runaround. At Altasciences, you’ll never feel ignored. With a central point of contact, the same program managers will stick with you for your entire journey with us. And if you ever need extra insight, our executive team is just a call away. No games—just a partner who’s always within reach.
-
They’re all talk.
Promises are great, but if your CRO keeps making commitments they can’t keep, it’s time to re-evaluate.
Altasciences won’t ghost you for the next big crush; you are our partner, not a simple transaction. We are a CRO/CDMO that’s fully committed to you and your project, and we believe in transparency, responsiveness, and the importance of being dependable and honest. You deserve nothing less.
Discover how Altasciences could be the right CRO for you:
VIDEO:The True Meaning of Moving in Unison
Ingrid Holmes, VP of Global Clinical Operations, and Lynne Le Sauteur, VP of Laboratory Sciences, discuss how the synergy between our clinical and bioanalytical teams drives our integrated solution.
BLOG: 4 Essential Topics to Cover in Your First CRO Meeting
Chad Rathlef, Executive Director of Strategic Partnerships, and Lisa Sanford, VP of Business Development, outline how to navigate this pivotal moment and set yourself up for a long-lasting partnership.
VIDEO: QUICK CHAT with Chris Perkin—One Operational Structure
Altasciences' CEO, Chris Perkin, discusses how our internal structure differs from other CROs and CDMOs, and how this addresses a major challenge within the industry and accelerates timelines for clients.
Discover the Art of Expert Formulation―From Concept to Clinic
Start Your Project Off on the Right Foot
Formulation development drives every phase of early drug development―from concept to clinic. It ensures precise dosing, drug stability, and safety while providing critical data for regulatory submissions.
This infographic shows how we design and optimize pharmaceutical formulations to maximize therapeutic benefits and ensure the safety of your clinical trials.
Do you have an active pharmaceutical ingredient (API) that needs to be formulated? Contact us today.
Related resources that may interest you:
- eBook: Achieving Optimal Formulation for Preclinical Testing
- eBook: Maximizing Drug Formulations for First-in-Human Trials
- Video: Key Steps in Complex and Customized Formulation Development
Tailored Manufacturing and Analytical Testing for Your Molecules
A CDMO You Can Count On.
From discovery to commercialization, our manufacturing team is dedicated to delivering high-quality and FDA-compliant products, every time.
Discover our full range of drug development, manufacturing, and analytical testing services for oral solid dosage forms, injectables, creams, and gels―including the shipping and handling of highly potent compounds and controlled substances.
With over 25 years of experience, in-house R&D and formulation laboratories, innovative platforms and technology, and an exceptional team of scientists, we are committed to providing you with the best manufacturing solutions for your program.
You can count on us!
Speak with one of our experts today to get started.
Related resources that may interest you:
How Combined CDMO and Clinical Teams Accelerate Drug Development
Streamlined Processes. Faster Approval.
In this new video, we share how our integrated teams’ combined expertise in clinical trials and manufacturing simplify the drug development process, empowering you to bring innovative therapies to market faster and, ultimately, improve patient outcomes.
Watch now to learn how our cohesive approach minimizes delays, reduces costs, and enhances collaboration.
Looking for drug development and manufacturing services? Speak with one of our experts today.
Related resources that may interest you:
- Webpage: Pharmaceutical Contract Manufacturing Services
- eBook: Advantages of Conducting Early-Phase Clinical Research in Canada
- Webinar: Overcoming Challenges in Manufacturing for Clinical Trials
Altasciences’ Commitment to Bioanalytical Excellence
Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services
We have been your trusted drug development research partner for over 30 years. We are committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs. Our flexible bioanalytical services from discovery to Phase IV empower our clients across every phase of research.
We recently launched the Unveiling the Invisible video campaign to showcase how our bioanalytical solutions provide critical insights that unveil the invisible and drive the creation of your innovative therapies.
RELATED RESOURCES
Our bioanalytical team excels in comprehensive bioanalytical services, including assay and method development, molecular biology, mass spectrometry, ligand binding assays, immunogenicity testing, biomarker analysis, flow cytometry services, and more, to support your journey from discovery through Phase IV.
Below are some resources that highlight our extensive knowledge, and wealth of bioanalytical experience.
- The Altascientist Issue 41: Immunomodulation Assessments for Clinical Trials—Sophisticated Bioanalytical Approaches to Support Complex Modalities
- eBook: Key Considerations for Nonclinical AAV Gene Therapy Development
- eBook: Key Biomarkers of Immunomodulation
- Scientific Research Article: A Novel Hybridization LC-MS/MS Methodology for Quantification of siRNA
- Scientific Research Article: A Validated Capillary Microsampling LC-MS Method for Quantification of ASOs in Mouse Serum
- Scientific Research Article: Microsampling in Pediatric Studies
BioBuzz: Part One—Exploring Philadelphia's CDMOs
Discover the Dynamic Landscape of GLP-1 Drug Development
In this issue of The Altascientist, we explore the current and future development of GLP-1 receptor agonists (GLP-1 RAs), and the complexities involved in the early phases.
Topics covered include preclinical models, bioanalytical assays, clinical study design, manufacturing, and the expanding applications of GLP-1 drugs in treating various health conditions. Exclusive case studies are also presented.
Questions about your drug development program? Speak with one of our experts.
Related resources that may interest you:
Going Above and Beyond to Exceed Your Expectations
In this new video, our clinical and manufacturing experts share how their teams collaborate and tailor solutions to meet your unique needs. They highlight real examples of going above and beyond by implementing innovative strategies to ensure your projects stay on track.
Looking for a more seamless drug development and manufacturing experience? Speak with one of our experts today.
Related resources that may interest you:
- Video: Nine Strategic Locations to Accelerate Study Timelines
- eBook: Maximizing Drug Formulation for First-in-Human Trials
- Webpage: Pharmaceutical Contract Manufacturing Services
- Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical
Liquid-Filled Capsules: An Attractive, Marketable Solution
A Scalable Solution for Solubility Challenges
Case Study: How to Ensure Safety While Manufacturing Highly Potent APIs
Highly potent active pharmaceutical ingredients (API) require careful attention to safety and handling during formulation and manufacturing. This blog explores the process required for manufacturing a highly potent API for an ophthalmic indication, based on a case study involving loteprednol etabonate, a topical corticosteroid used to treat eye inflammations.